In 2006, the creation of sofie launched the aspiration of having a multifaceted approach to expand the reach of pet products for patients with advanced imaging needs This was further realized in 2017 with the addition of a radiopharmacy network with global distribution capabilities. Transparency in coverage (tic) regulations requires health insurers and group health plans to post their provider link on company websites View sofie’s link here view our privacy policy Our team works alongside our pharma and academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease. Our product lines include fdg, pylarify, neuraceq, and other clinical trial products.
Sofie is continuing to accept applications for our fapi outreach program This program aims to raise awareness and foster collaboration in the field of molecular imaging, specifically focusing on fibroblast activation protein inhibitor (fapi) studies.
OPEN
